Hazem Elewa1, Dania Alkhiyami2, Dima Alsahan2, Ahmed Abdel-Aziz3. 1. Clinical Pharmacy and Practice Section, Qatar University, Doha, Qatar. 2. College of Pharmacy, Qatar University, Doha, Qatar. 3. Hamad General Hospital, Doha, Qatar.
Abstract
RATIONALE, AIMS AND OBJECTIVES: Pharmacists are expected to play an important role in applying pharmacogenomics discoveries to patient care. Despite the increased attention to genetic research in Qatar, clinicians' attitudes towards the application of pharmacogenomics are not yet explored. The aim of this study was to assess the awareness and attitude of pharmacists compared with doctors towards pharmacogenomics and its implications by submitting an electronic-based survey to all pharmacists and doctors currently working in a large medical corporation in Qatar. METHODS: A cross-sectional survey instrument was developed based on literature review. Eligible participants were pharmacists and doctors currently practicing in Hamad Medical Corporation hospitals in Qatar. The survey comprised questions on demographic and professional characteristics. It also evaluated the awareness, attitudes and challenges towards pharmacogenomics and its application. RESULTS: We collected 202 surveys, 108 (53.2%) of which were pharmacists and the remaining 94 (46.5%) were doctors. The overall participants' mean total awareness score percentage was low (39% ± 22) and there were no difference between the mean score achieved by pharmacists and doctors. Pharmacists had significantly more positive attitudes than doctors towards: (i) taking the responsibility of applying pharmacogenomics to drug therapy selection, dosing and monitoring; (ii) perceiving a positive role of pharmacogenomics testing on the control of drug expenditure; and (iii) their willingness to participate in pharmacogenomics-related training sessions. Both pharmacists and doctors perceived lack of knowledge and guidelines as major challenges towards the application of pharmacogenomics in Qatar. CONCLUSION: Despite doctors' and pharmacists' low level of awareness towards pharmacogenomics, they both have positive attitudes towards the clinical implications of pharmacogenomics. Pharmacists are more motivated to learn about pharmacogenomics and are more willing to take initiatives in its clinical application and patient education.
RATIONALE, AIMS AND OBJECTIVES: Pharmacists are expected to play an important role in applying pharmacogenomics discoveries to patient care. Despite the increased attention to genetic research in Qatar, clinicians' attitudes towards the application of pharmacogenomics are not yet explored. The aim of this study was to assess the awareness and attitude of pharmacists compared with doctors towards pharmacogenomics and its implications by submitting an electronic-based survey to all pharmacists and doctors currently working in a large medical corporation in Qatar. METHODS: A cross-sectional survey instrument was developed based on literature review. Eligible participants were pharmacists and doctors currently practicing in Hamad Medical Corporation hospitals in Qatar. The survey comprised questions on demographic and professional characteristics. It also evaluated the awareness, attitudes and challenges towards pharmacogenomics and its application. RESULTS: We collected 202 surveys, 108 (53.2%) of which were pharmacists and the remaining 94 (46.5%) were doctors. The overall participants' mean total awareness score percentage was low (39% ± 22) and there were no difference between the mean score achieved by pharmacists and doctors. Pharmacists had significantly more positive attitudes than doctors towards: (i) taking the responsibility of applying pharmacogenomics to drug therapy selection, dosing and monitoring; (ii) perceiving a positive role of pharmacogenomics testing on the control of drug expenditure; and (iii) their willingness to participate in pharmacogenomics-related training sessions. Both pharmacists and doctors perceived lack of knowledge and guidelines as major challenges towards the application of pharmacogenomics in Qatar. CONCLUSION: Despite doctors' and pharmacists' low level of awareness towards pharmacogenomics, they both have positive attitudes towards the clinical implications of pharmacogenomics. Pharmacists are more motivated to learn about pharmacogenomics and are more willing to take initiatives in its clinical application and patient education.
Authors: Tien M Truong; Jeffrey L Apfelbaum; Emily Schierer; Keith Danahey; Brittany A Borden; Theodore Karrison; Sajid Shahul; Magdalena Anitescu; Rebecca Gerlach; Randall W Knoebel; David O Meltzer; Mark J Ratain; Peter H O'Donnell Journal: Pharmacogenet Genomics Date: 2022-04-01 Impact factor: 2.089
Authors: Amina M Bagher; Thikryat Neamatallah; Ghadeer Balto; Lina Almikhy; Sara S Almutairi; Mohammed O Abushal; Khlood Baghlaf; Sara M Bagher Journal: Saudi Pharm J Date: 2020-12-30 Impact factor: 4.330
Authors: Azhar T Rahma; Mahanna Elsheik; Bassam R Ali; Iffat Elbarazi; George P Patrinos; Luai A Ahmed; Fatma Al Maskari Journal: J Pers Med Date: 2020-11-09
Authors: Azhar T Rahma; Mahanna Elsheik; Iffat Elbarazi; Bassam R Ali; George P Patrinos; Maitha A Kazim; Salma S Alfalasi; Luai A Ahmed; Fatma Al Maskari Journal: J Pers Med Date: 2020-10-24